Olet täällä

testosteroni

Anaboliset steroidit ja testosteroni

Päivitetty 2.4.2020

[1] Davis S, Wahlin-Jacobsen S. Testosterone in women-the clinical significance. Lancet Diabetes Endocrinol. 2015;3(12):980-92
 
[2] Kadi F. Cellular and molecular mechanisms responsible for the action of testosterone on human skeletal muscle. A basis for illegal performance enhancement. Br J Pharmacol. 2008;154(3):522–528
 
[3] Huhtaniemi I. Androgeenit. Teoksessa: Välimäki M, Sane T, Dunkel L. Endokrinologia. 2009. Duodecim Oy
 
[4] Handelsman D. Commentary: Androgens and “anabolic steroids”: the one-headed janus. Endocrinology. 2011;152(5):1752-1754
 
[5] Frati P, Busardò FP, Cipolloni L, Dominicis ED, Fineschi V. Anabolic androgenic steroid (AAS) related deaths: autoptic, histopathological and toxicological findings. Curr Neuropharmacol. 2015;13(1):146–59
 
[6] Kuhn CM. Anabolic Steroids. Recent Prog Horm Res. 2002; 57:411–34
 
[7] Kicman A. Pharmacology of anabolic steroids. Br J Pharmacol. 2008;154(3):502–521
 
[8] Hall RC, Hall RC. Abuse of supraphysiologic doses of anabolic steroids. South Med J. 2005;98(5):550–5
 
[9] Nieschlag E, Nieschlag S. Testosterone deficiency: a historical perspective. Asian J Androl. 2014; 16:161-168
 
[10] Nieschlag E, Nieschlag S. Endocrine history: The history of discovery, synthesis and development of testosterone for clinical use. European J Endocrinol. 2019; 180:6
 
[11] Davey R, Grossmann M. Androgen receptor structure, function and biology: From bench to bedside. Clin Biochem Rev. 2016;37(1):3–15
 
[12] Serra C, Bhasin S, Tangherliini F, Barton E, Ganno M, Zhang A, Shansky J, Vandenburgh H, Travison T, Jasuja R, Morssi C. The role of GH and IGF-1 mediating anabolic effects of testosterone on androgen-responsive muscle.
Endocrinology. 2011;152(1):193-206
 
[13] KELA. Lääkekorvausten saajat ja reseptitiedot- Testosteroni 2008-2019. 2020
 
[14] Handelsman D. Global trends in testosterone prescribing, 2000-20011: expanding the spectrum of prescription drug misuse. Med J Aust. 2013;199(8):548-51
 
[15] Gabrielsen J, Najari B, Alukal J, Eisenberg M. Trends in testosterone prescription and public health concerns. Urol Clin North Am. 2016;43(2):261-71
 
[16] Bahrke & Yesalis. Abuse of anabolic androgenic steroids and related substances in sport and exercise. Current Opinion in Pharmacology. 2004; 4: 614–620
 
[17] Seppälä & Karila. Suorituskykyyn vaikuttavien aineiden väärinkäyttö. Käytännön Lääkäri. 1996; 3: 129–135
 
[18] Wright S, Grogan S, Hunter G. Motivations for anabolic steroid use among bodybuilders. J Health Psych. 2000;5(4):566-571
 
[19] Kimergård A. A qualitative study of anabolic steroid use amongst gym users in the United Kingdom: motives, beliefs and experiences. J Subst Use. 2014;20(4):288-294
 
[20] Cohen J, Collins R, Darkes J. A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. J Int Soc Sports Nutr. 2007; 4:12
 
[21] McVeigh J, Bates G, Chandler M. Steroids and image enhancing drugs. 2014 Survey results. 2015. Public Health Wales, Liverpool John Moores University
 
[22] Pope H, Wood R, Rogol A, Nyberg F, Bowers L, Bhasin S. Adverse health consequences of performance-enhancing drugs: An endocrine society scientific statement. Endocr Rev. 2014;35(3):341-375
 
[23] Pärssinen, Kujala, Vartiainen, Sarna & Seppälä. Increased premature mortality of competitive powerlifters suspected to have used anabolic agents. International Journal of Sports Medicine. 2000; 21: 225–227
 
[24] Horwitz H, Andersen J, Dalhoff K. Health consequences of androgenic anabolic steroid use. J Intern Med. 2019;285(3):333-340
 
[25] Taimela & Seppälä. Voimaharjoittelussa käytettävien anabolisten aineiden haitat. Suomen Lääkärilehti. 1994; 20–21: 2051–2061
 
[26] Karila, Hovatta, Seppälä (2004): Concomitant abuse of anabolic androgenic steroids and human chorion gonadotropin impairs spermatogenesis in power athletes. International Journal of Sports Medicine. 2004; 25: 257-263
 
[27] Kuhn CM. Anabolic Steroids. Recent Prog Horm Res. 2002; 57:411–34
 
[28] Büttner A, Thieme D. Side effects of anabolic androgenic steroids: Pathological findings and structure-activity relationships. Handb Exp Pharmacol. 2010;(195):459–84
 
[29] Van Amsterdam J, Opperhuizen A, Hartgens F. Adverse effects of anabolic-androgenic steroids. Regul Toxico Pharmacol. 2010;57(1):117-123
 
[30] Sarikaya H, Peters C, Schulz T, Schönfelder, Michna H. 2007. Biomedical Side Effects of Doping. International Symposium Munich, Germany. “Harmonising the Knowledge About Biomedical Side Effects of Doping” -Project of the European Union
 
[31] Kanayama, Hudson & Pope. Long-term psychiatric and medical consequences of anabolic–androgenic steroid abuse: A looming public health concern? Drug and Alcohol Dependence. 2008; 98: 1–12
 
[32] Mäntysaari, Karila & Seppälä. Cardiovascular findings in power athletes abusing anabolic androgenic steroids. International Review of the Armed Forces Medical Services. 2005; 75: 12–15
 
[33] Thiblin, Mobini-Far & Frisk. Sudden unexpected death in a female fitness athlete, with a possible connection to the use of anabolic androgenic steroids (AAS) and ephedrine. Forensic Science International. 2009; 184: e7–e11
 
[34] Nieschlag E, Vorona E. Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions. Rev Endo Metab Dis. 2015;16(3):199-211
 
[35] Hickson R, Ball K, Falduto M. Adverse effects of anabolic steroids. Med Toxic Adv Drug Exp. 1989;4(4):254-271
 
[36] Hope V, Harris R, McVeigh J, Cullen K, Smith J, Parry J, DeAngelis D, Ncube F. Risk of HIV and hepatitis B and C over time among men who inject image and performance enhancing drugs in England and Wales: Results from cross-sectional prevalence surveys 1992-2013. J Acquir Immune Defic Syndr. 2016:71(3):331-337
 
[37] Pärssinen & Seppälä. Steroid use and long-term health risks in former athletes. Sports Medicine. 2002; 32(2): 83–94
 
[38] Giammanco, Tabacchi, Giammanco, Di Majo & La Guardia. Testosterone and aggressiveness. Medical Science Monitor. 2005; 11(4): 136–145
 
[39] Kanayama G, Brower KJ, Wood RI, et al. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009; 104:1966–1978
 
[40] Ip E, Lu D, Barnet M, Tenerowicz M, Vo J, Perry P. Psychological and physical impact of anabolic-androgenic steroid dependence. Pharmacotherapy. 2012;32(10):910–9
 
[41] Lundholm L, Käll K, Wallin S, Thiblin I. Use of anabolic androgenic steroids in substance abusers arrested for crime. Drug Alcohol Depend. 2010;111(3):222–6
 
[42] Lood Y, Eklund A, Garle M, Ahlner J. Anabolic androgenic steroids in police cases in Sweden 1999–2009. Forensic Sci Int. 2012;219(1–3):199–204
 
[43] Lundholm L, Frisell T, Lichtenstein P, Långström N. Anabolic androgenic steroids and violent offending: confounding by polysubstance abuse among 10,365 general population men. Addiction. 2015;110(1):100–8 101 
 
[44] Onakomaiya M, Henderson L. Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors. Psychopharmacology. 2016;233(4):549–569